Patents Assigned to IMMUNOWORK, LLC
  • Patent number: 11266717
    Abstract: Compositions, methods, and kits are for the diagnosis, prevention and/or treatment of autoimmune diseases by detecting, targeting, and/or eliminating epitope-specific autoimmune cells. The compositions include a conjugate of an epitope and an agent that allows for detecting, targeting, and/or eliminating epitope-specific autoimmune cells.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: March 8, 2022
    Assignee: IMMUNOWORK, LLC
    Inventor: Quansheng Zhu